Publikationen pro Jahr
Publikationen pro Jahr
-
Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study.
Moser, T. (Erstautor/-in), OSullivan, C. (Co-Autor/-in), Otto, F. (Co-Autor/-in), Hitzl, W. (Co-Autor/-in), Pilz, G. (Co-Autor/-in), Schwenker, K. (Co-Autor/-in), Mrazek, C. (Co-Autor/-in), Haschke-Becher, E. (Co-Autor/-in), Trinka, E. (Co-Autor/-in), Wipfler, P. (Co-Autor/-in) & Harrer, A. (Letztautor/-in), 22 Apr. 2022, in: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 15, S. 17562864221092092Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
6 Quellenangaben (Web of Science) -
Misinterpretation of glioblastoma as ADEM: potentially harmful consequences of over-diagnosis of COVID-19 vaccine-associated adverse events.
O Sullivan, C. (Erstautor/-in), Zach, F., Moser, T. (Co-Autor/-in), Pilz, G. (Co-Autor/-in), Harrer, A. (Co-Autor/-in), Trinka, E. (Co-Autor/-in), Enzinger, C., Pfaff, J. (Co-Autor/-in) & Wipfler, P. (Letztautor/-in), 2022, in: JOURNAL OF NEUROLOGY . 269, 2, S. 616-618Publikation: Beitrag in Fachzeitschrift › Letter to the editor › Begutachtung
4 Quellenangaben (Web of Science) -
Recall response to COVID-19 antigen is preserved in people with multiple sclerosis on anti-CD20 medications - A pilot study.
Moser, T. (Erstautor/-in), Otto, F. (Co-Autor/-in), O"Sullivan, C. (Co-Autor/-in), Hitzl, W. (Co-Autor/-in), Pilz, G. (Co-Autor/-in), Harrer, A. (Co-Autor/-in), Trinka, E. (Co-Autor/-in) & Wipfler, P. (Letztautor/-in), 24 Jan. 2022, in: Multiple Sclerosis and Related Disorders. 59, S. 103560Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung
11 Quellenangaben (Web of Science)